News / Korea / yonhap_finance
COVID-19 Diagnostic and Pharmaceutical Stocks Rally Amid Resurgence Concerns
Health Technology · Biotechnology · yonhap_finance · 2026-08-24
019170, 096530, 114450, 253840
Shares of COVID-19 diagnostic kit manufacturers and pharmaceutical companies surged in early trading following reports of a sharp rise in infection rates.
What Happened
Market Reaction: Concerns over a resurgence of COVID-19 have triggered a rally in related stocks within the Korean market. On the 24th, diagnostic kit manufacturer Sugentech saw a sharp increase in early trading, while Seegene and Shinpoong Pharmaceutical also experienced significant gains.
Data Context: Recent reports indicate that the domestic COVID-19 detection rate reached 9.1% for the week of September 9th to 15th. This represents a 3.4 percentage point increase from the previous week's 5.7%, signaling a notable uptick in viral transmission.
Sector Impact: The positive momentum has spread across the diagnostic and pharmaceutical sectors, as investors anticipate increased demand for testing and potential treatments. Market participants are closely monitoring the infection trends to gauge the duration of this demand.
Investment Caution: Stocks linked to infectious disease outbreaks are known for high volatility driven by news headlines. Investors are advised to exercise caution, as these price movements are often fueled by short-term sentiment rather than immediate fundamental improvements.